Bret Lashner

Safety and Efficacy of Fecal Microbiota Spores, Live-brpk (Formerly SER-109) in Older Patients With Recurrent <italic>Clostridioides difficile</italic> Infection: Findings From an Integrated Analysis of Phase 3 Trials

1 Department of Gastroenterology, Hepatology & Nutrition, Cleveland Clinic Main Campus, Cleveland, Ohio, United States; 2 Seres Therapeutics, Cambridge, Massachusetts, United States; ...

Bret Lashner ;

Lisa L. von Moltke , MD, FCPP;

Darrell S. Pardi ;

01/11/2024

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

November 23 ⁠–⁠ November 24

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

December 12 ⁠–⁠ December 13

December 14 ⁠–⁠ December 15

February 2 ⁠–⁠ February 5

February 27 ⁠–⁠ March 1

March 17 ⁠–⁠ March 19

See Full Calendar

Bret Lashner

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products